 |
|||||
|
|||||
|
Many pharmaceutical stocks are receiving positive earnings estimate revisions. Within Medical-Drugs, there are currently 7 Zacks #1 Rank ("strong buy") and 27 Zacks #2 Rank ("buy") stocks.
Today's Top Stories: Thursday- October 23, 2008
ZACKS RANK BUY STOCKS
Sponsor
Just Posted: 10 Stocks to Own Before the Election Our Zacks analyst team just uncovered 10 companies primed to pop over the next year with strong fundamentals and earnings on the upswing. Five may get a big head start in their stock prices right after the U.S. presidential election. At Zacks, we’re not taking sides. Our focus is on taking profits. Learn more about these well-timed investments before Obama or McCain wins on November 4, 2008. BEST OF ZACKS EQUITY RESEARCH
EDUCATION: Growth & Income
PeopleAndPicks.com:
PROFIT TRACKS: Earnings and Margins
EARNINGS TRENDS: Estimates Sliding Away OTHER ZACKS RESOURCES:
Manage your Profit from the Pros subscription: REFER-A-FRIEND
If you enjoy this e-mail newsletter, then please pass it along to a friend. Simply forward them the link below to sign up for their own free subscription. THANKS! Regards and Happy Investing,
Charles Rotblut, CFA p.s. What is the mission for Zacks Profit from the Pros? To find out how we will help you become a more successful investor, click here.
|
|||||
|
Visit /performance for information about the performance numbers displayed in this newsletter. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. To contact us by mail:
Zacks Investment Research
To unsubscribe from receiving "Zacks.com Profit from the Pros" |
|||||
- Latest News
- Most Popular
- Roundtable Top Picks of the Week
- Anatomy of Success: Green Mountain Coffee
- The Mega-Rally Rolls On
- AWS 5/21: The Beginning of the End for QE
- RTI: Prediction Contest: S&P 500 on Dec. 31st
- Industry Rank Analysis: Shifting Into Overdrive
- Biotechnology ETF Investing 101
- 3 Dividend Stocks at Reasonable Prices
- Buy These ETFs to Profit from "Sector Rotation"
- Options Strategies & the Zacks Rank
- PFP 5/21: Below the Surface
Recent Quotes
| No Recent Quote currently available |
My Portfolio
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks #1 Stocks on the Move 05/20/2013
| Company Name | Symbol | %Change |
|---|---|---|
| ORBOTECH LTD | ORBK | 10.86% |
| SONIC FOUNDR | SOFO | 9.45% |
| VIPSHOP HOLD | VIPS | 9.20% |
| RENEWABLE EN | REGI | 8.98% |
| EAGLE BULK S | EGLE | 7.84% |
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.